Professor Judy Coulson PhD
Professor Molecular Physiology & Cell Signalling
- +44 (0)151 794 5850
- Work email J.Coulson@liverpool.ac.uk
- About
- Research
- Publications
- Teaching
- Professional Activities
Research
Roles of reversible ubiquitination in cell signalling, cell cycle and transcription.
Transcriptional regulation in lung cancer.
Translational research in mesothelioma and lung cancer
Research Grants
Developing a chick embryo model to aid in development of personalised therapies for malignant pleural mesothelioma
NATIONAL CENTRE FOR THE REP, REF AND RED OF ANIMALS USED IN RESEARCH (NC3RS)
November 2019 - January 2023
Integrative analysis of BAP1-dependencies to identify novel therapeutic targets for uveal melanoma: learning lessons from the lung
FIGHT FOR SIGHT (UK)
October 2019 - December 2022
Translating discovery science: DUBs that regulate centrosome clustering, an Achilles' heel of cancer
BREAST CANCER NOW (UK)
October 2019 - September 2023
The Role of Reversible Ubiquitination in Virus Infection
ROYAL EMBASSY OF SAUDI ARABIA CULTURAL BUREAU IN LONDON (UK)
October 2016 - September 2020
Translating BAP1 dependencies for precision therapy of mesothelioma
BRITISH LUNG FOUNDATION (UK)
March 2017 - March 2021
Wellcome Trust Four-Year PhD Studentship with the Cellular and Molecular Physiology PhD Programme
WELLCOME TRUST (UK)
October 2015 - September 2019
Mechanistic study of the reduction of RBM4 in cancer and its role in regulating the oncogenic SRSF1
DEPARTMENT FOR BUSINESS, INNOVATION AND SKILLS (UK)
March 2015 - March 2018
Investigating in vivo resistance mechanisms to MEK inhibitors in uveal melanoma to enable novel combinatorial therapies.
NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH - NWCR (UK)
March 2016 - May 2019
S18-phosphorylation controls catalytic activity of the cancer-associated deubiquitylase USP7: defining the implications for cancer biology and USP7 inhibitor therapy
NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH - NWCR (UK)
October 2016 - December 2019
Wellcome trust four-year PhD studentship with the cellular and molecular physiology PhD programme
WELLCOME TRUST (UK)
October 2012 - September 2016
Wellcome Trust Four-Year PhD Studentship with the Cellular and Molecular Physiology Programme
WELLCOME TRUST (UK)
October 2011 - March 2016
Regulation and substrate-specificity for isoforms of the debiquitinase USP15 during the cell cycle
NORTH WEST CANCER RESEARCH FUND
February 2013 - February 2015
Isogenic cell lines for targeted therapy discovery and development in BAP1-deficient mesothelioma
BRITISH LUNG FOUNDATION (UK)
October 2012 - January 2016
Targeting an Achilles’ heel of cancer: Deubiquitylases as novel targets for centrosome de-clustering and cancer-cell specific cell death
NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH - NWCR (UK)
March 2015 - February 2018
Wellcome Trust four year PhD studentship with the Cellular and Molecular Physiology Programme
WELLCOME TRUST (UK)
October 2013 - September 2017
Novel isogenic models of BAP1-deficient uveal melanoma for drug discovery
FIGHT FOR SIGHT (UK)
October 2014 - September 2018